Optimal triage test characteristics to improve the cost-effectiveness of the Xpert MTB/RIF assay for TB diagnosis: A decision analysis

PLoS ONE

Volumn 8, Issue 12, 2013, Pages

  Van't Hoog, Anna H ^a,b   Cobelens, Frank ^a,b   Vassall, Anna ^c   Van Kampen, Sanne ^d   Dorman, Susan E ^e   Alland, David ^f   Ellner, Jerrold ^g  

^a AMSTERDAM INSTITUTE FOR GLOBAL HEALTH AND DEVELOPMENT   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d KNCV TUBERCULOSIS FOUNDATION   (Netherlands)

^e JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^g BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGORITHM; ANALYTIC METHOD; ARTICLE; BIOASSAY; COHORT ANALYSIS; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; HUMAN; INDIA; LOWEST INCOME GROUP; MAJOR CLINICAL STUDY; MTB RIF ASSAY; PREVALENCE; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; TUBERCULOSIS; UGANDA;

ALGORITHMS; COST-BENEFIT ANALYSIS; DECISION SUPPORT TECHNIQUES; HUMANS; INDIA; SOUTH AFRICA; TRIAGE; TUBERCULOSIS; UGANDA;

EID: 84893412967     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0082786     Document Type: Article

References (31)

1. Abu-Raddad LJ, Sabatelli L, Achterberg JT, Sugimoto JD, Longini IM, Jr., et al. (2009) Epidemiological benefits of more-effective tuberculosis vaccines, drugs, and diagnostics. 106: 13980-13985.
2. Dye C, Williams BG (2010) The population dynamics and control of tuberculosis. 328: 856-861.
3. Ling DI, Flores LL, Riley LW, Pai M (2008) Commercial nucleic-acid amplification tests for diagnosis of pulmonary tuberculosis in respiratory specimens: meta-analysis and meta-regression. PLoS One 3: e1536. 10.1371/journal.pone.0001536 [doi].
4. Boehme CC, Nicol MP, Nabeta P, Michael JS, Gotuzzo E, et al. (2011) Feasibility, diagnostic accuracy, and effectiveness of decentralised use of the Xpert MTB/RIF test for diagnosis of tuberculosis and multidrug resistance: a multicentre implementation study. 377: 1495-1505.
5. Helb D, Jones M, Story E, Boehme C, Wallace E, et al. (2010) Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol 48: 229-237. JCM.01463-09 [pii];10.1128/JCM.01463-09 [doi].
6. World Health Organization (2013) WHO monitoring of Xpert MTB/RIF roll-out. http://www.who.int/tb/laboratory/mtbrifrollout/en/index.html. Accessed 2013 Mar 1.
7. Weyer K, Mirzayev F, Migliori GB, van Gemert W, D'Ambrosio L, et al. (2013) Rapid molecular TB diagnosis: Evidence, policy making and global implementation of Xpert MTB/RIF. Eur Respir J 42. Review.
8. Lawn SD, Mwaba P, Bates M, Piatek A, Alexander H, et al. (2013) Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis 13: 349-361. S1473-3099(13)70008-2 [pii];10.1016/S1473-3099(13)70008-2 [doi].
9. Vassall A, van Kampen S., Sohn H, Michael JS, John K, et al. (2011) Rapid diagnosis of tuberculosis with the Xpert MTB/RIF assay in high burden countries: a cost-effectiveness analysis. PLoS Med 8: e1001120. 10.1371/journal.pmed.1001120 [doi];PMEDICINE-D-11-00805 [pii].
10. Menzies NA, Cohen T, Lin HH, Murray M, Salomon JA (2012) Population Health Impact and Cost-Effectiveness of Tuberculosis Diagnosis with Xpert MTB/RIF: A Dynamic Simulation and Economic Evaluation. PLoS Med 9: e1001347. 10.1371/journal.pmed.1001347 [doi];PMEDICINE-D-11-02547 [pii].
11. World Health Organization (2012) CHOosing Interventions that are Cost Effective (WHO-CHOICE). http://www.who.int/choice/en/. Accessed 2012 Dec 15.
12. Shillcutt SD, Walker DG, Goodman CA, Mills AJ (2009) Cost effectiveness in low- and middle-income countries: a review of the debates surrounding decision rules. Pharmacoeconomics 27: 903-917. 3 [pii];10.2165/10899580- 000000000-00000 [doi].
13. Weyer K, Carai S, Nunn P (2011) Viewpoint TB diagnostics: what does the world really need? J Infect Dis 204 Suppl 4: S1196-S1202. jir452 [pii];10.1093/infdis/jir452 [doi].
14. World Health Organization (2011) Policy Statement: Automated Real-time Nucleic Acid Amplification Technology for Rapid and Simultaneous Detection of Tuberculosis and Rifampicin Resistance: Xpert MTB/RIF System.
15. Pantoja A, Fitzpatrick C, Vassall A, Weyer K, Floyd K (2012) Xpert MTB/RIF for diagnosis of TB and drug-resistant TB: a cost and affordability analysis. Eur Respir J. 09031936.00147912 [pii];10.1183/09031936.00147912 [doi].
16. Ngadaya ES, Mfinanga GS, Wandwalo ER, Morkve O (2009) Detection of pulmonary tuberculosis among patients with cough attending outpatient departments in Dar Es Salaam, Tanzania: does duration of cough matter? BMC Health Serv Res 9: 112.
17. Otero L, Ugaz R, Dieltiens G, Gonzalez E, Verdonck K, et al. (2010) Duration of cough, TB suspects' characteristics and service factors determine the yield of smear microscopy. Trop Med Int Health 15: 1475-1480.
18. Mabaera B, Lauritsen JM, Katamba A, Laticevschi D, Naranbat N, et al. (2007) Sputum smear-positive tuberculosis: empiric evidence challenges the need for confirmatory smears. Int J Tuberc Lung Dis 11: 959-964. (Pubitemid 47425021)
19. Wallis RS, Pai M, Menzies D, Doherty TM, Walzl G, et al. (2010) Biomarkers and diagnostics for tuberculosis: progress, needs, and translation into practice. Lancet 375: 1920-1937.10.1016/S0140-6736(10)60359-5 [doi].
20. Hayen A, Macaskill P, Irwig L, Bossuyt P (2010) Appropriate statistical methods are required to assess diagnostic tests for replacement, add-on, and triage. J Clin Epidemiol 63: 883-891. S0895-4356(09)00306-0 [pii];10.1016/j. jclinepi.2009.08.024 [doi].
21. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, et al. (2012) Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 380: 2197-2223. S0140-6736(12)61689-4 [pii];10.1016/S0140-6736(12) 61689-4 [doi].
22. The World Bank (2012) Data/GDP per capita (current US$). http://data.worldbank.org/indicator/NY.GDP.PCAP.CD Accessed 2012 Oct 3.
23. van't Hoog AH, Meme HK, van Deutekom H, Mithika AM, Olunga C, et al. (2011) High sensitivity of chest radiograph reading by clinical officers in a tuberculosis prevalence survey. Int J Tuberc Lung Dis 15: 1308-1314.
24. Stop TB Department (2012) Buy-down agreement to reduce cost of Xpert MTB/RIF cartridges by 40% for high-burden countries. http://www.stoptb.org/wg/ new-diagnostics/assets/documents/News-XpertPrice-21Aug12.pdf. Accessed 2012 Oct 3.
25. Stothard JR (2009) Improving control of African schistosomiasis: towards effective use of rapid diagnostic tests within an appropriate disease surveillance model. Trans R Soc Trop Med Hyg 103: 325-332. S0035-9203(08)00553-1 [pii];10.1016/j.trstmh.2008.12.012 [doi].
26. Batwala V, Magnussen P, Hansen KS, Nuwaha F (2011) Cost-effectiveness of malaria microscopy and rapid diagnostic tests versus presumptive diagnosis: implications for malaria control in Uganda. Malar J 10: 372. 1475-2875-10-372 [pii];10.1186/1475-2875-10-372 [doi].
27. Schackman BR, Neukermans CP, Fontain SN, Nolte C, Joseph P, et al. (2007) Cost-effectiveness of rapid syphilis screening in prenatal HIV testing programs in Haiti. PLoS Med 4: e183. 06-PLME-RA-0834R2 [pii];10.1371/journal.pmed. 0040183 [doi].
28. Schnippel K, Rosen S, Shearer K, Martinson N, Long L, et al. (2013) Costs of inpatient treatment for multi-drug-resistant tuberculosis in South Africa. Trop Med Int Health 18: 109-116. 10.1111/tmi.12018 [doi].
29. White MT, Conteh L, Cibulskis R, Ghani AC (2011) Costs and cost-effectiveness of malaria control interventions - a systematic review. Malar J 10: 337. 1475-2875-10-337 [pii];10.1186/1475-2875-10-337 [doi].
30. Hogeweg L, Mol C, de Jong PA, Dawson R, Ayles H, et al. (2010) Fusion of local and global detection systems to detect tuberculosis in chest radiographs. Med Image Comput Comput Assist Interv 13: 650-657.
31. Lonnroth K, Castro KG, Chakaya JM, Chauhan LS, Floyd K, et al. (2010) Tuberculosis control and elimination 2010-50: cure, care, and social development. 375: 1814-1829. Diseases